Collection Date: Feb 10, 2026 · Report: Feb 12, 2026
ID: FF05465495 · Lab: LAB-TH-20260210-5495 · Venous Blood · Fasting
Physician: Dr. Sierra Simpson, PhD
Optimal
Normal
Borderline
Out of Range
Critical
AI-generated personalized analysis based on your biomarker data
Merideth, your comprehensive blood panel results are in. With an overall Health Score of 93/100, your blood work looks excellent. Out of 39 biomarkers tested, 30 are in the optimal range and 5 are within normal limits. 2 markers fell outside the reference range. Your Liver Function, Kidney Function, Blood Health systems are functioning well. Risk assessments show low risk for Type 2 Diabetes, Liver Disease, Kidney Disease, Anemia. Since your last panel, your Health Score improved by 9 points — your efforts are paying off.
What your blood work says you're doing right
Your overall health score of 93/100 is outstanding, with 30 out of 39 biomarkers in the optimal range.
Your Complete Blood Count is optimal, and your Liver Function is excellent (94/100), indicating robust health in these crucial systems.
You have a low risk for Type 2 Diabetes, Liver Disease, Kidney Disease, and Anemia, which is a significant positive indicator.
Your Immune System is performing very well (88/100), suggesting good resilience and defense.
4 panels covering 39 biomarkers
Evaluates kidney function, liver function, electrolyte balance, and blood sugar levels
Fasting glucose within normal range. Continue monitoring annually.
Kidney filtration rate is normal. Slight decrease from previous — age-appropriate.
Slight increase from previous. Still within optimal range. Monitor at next visit.
Measures red and white blood cells, hemoglobin, and platelets to assess overall blood health
Measures cholesterol and triglyceride levels to assess cardiovascular risk
Total cholesterol slightly elevated. Consider dietary modifications and recheck in 3 months.
LDL above optimal. Increased cardiovascular risk. Dietary and lifestyle interventions recommended.
HDL is in the protective range. Excellent cardiovascular protection.
Triglycerides approaching upper limit. Reduce refined carbohydrates and increase omega-3 intake.
Ratio at the upper edge of optimal. HDL is providing good protection against LDL.
Measures systemic inflammation levels that correlate with chronic disease risk
Mild elevation in inflammatory marker. May correlate with gut microbiome dysbiosis detected in separate analysis.
How your biomarkers map to major body systems
Elevated LDL cholesterol and rising triglycerides indicate moderate cardiovascular risk. HDL provides protective benefit.
Total cholesterol at 218 mg/dL exceeds the desirable range. LDL at 138 mg/dL is the primary driver. However, HDL at 62 mg/dL provides meaningful cardioprotection. The TC/HDL ratio of 3.5 remains acceptable. Rising hsCRP (1.8 mg/L) suggests low-grade inflammation that may compound lipid-related risk.
All liver enzymes within optimal ranges. Excellent hepatic function with no signs of stress or damage.
AST (24 U/L) and ALT (28 U/L) are both well within normal limits. Alkaline phosphatase (68 U/L) is optimal. Total bilirubin (0.8 mg/dL) and albumin (4.3 g/dL) confirm healthy liver synthesis and detoxification capacity.
Kidney filtration and waste clearance are functioning well. eGFR shows age-appropriate performance.
eGFR at 88 mL/min is normal for age 63. BUN (16 mg/dL) and creatinine (0.85 mg/dL) indicate efficient waste filtration. Electrolytes (Na, K, Cl) are all balanced within optimal ranges.
Complete blood count shows excellent red and white blood cell parameters. No signs of anemia or infection.
Hemoglobin (13.8 g/dL) and hematocrit (41.2%) are solidly in the optimal range. White blood cell count (6.2 K/uL) and differential are normal, indicating a healthy immune response. Platelets (245 K/uL) are optimal for clotting function.
Fasting glucose is normal but approaching the upper end. Metabolic function is good with room for optimization.
Fasting glucose at 94 mg/dL is normal but above the optimal threshold of 90. Combined with triglycerides at 142 mg/dL (borderline), there are early signs that metabolic efficiency could be improved through dietary changes, particularly reducing refined carbohydrates.
White blood cell differential is balanced. Inflammatory markers show mild elevation worth monitoring.
Neutrophil-to-lymphocyte ratio is healthy. hsCRP at 1.8 mg/L indicates low-grade inflammation — not alarming but worth addressing through anti-inflammatory diet and gut health optimization. ESR (14 mm/hr) is within normal limits.
Calculated risk levels based on your biomarker profile
Elevated LDL and rising triglycerides increase 10-year cardiovascular risk. HDL provides partial protection.
Implement Mediterranean diet, increase omega-3 fatty acids, and add 30 minutes of daily aerobic exercise. Recheck lipids in 3 months.
Fasting glucose is normal. No current indicators of insulin resistance, though triglyceride trend warrants attention.
Continue annual glucose monitoring. Consider HbA1c testing for comprehensive assessment.
hsCRP mildly elevated, suggesting low-grade systemic inflammation. May correlate with gut microbiome findings.
Anti-inflammatory diet rich in polyphenols, turmeric, and omega-3s. Address gut dysbiosis if present in microbiome report.
All liver markers within optimal ranges. No evidence of hepatic stress or fatty liver disease.
Continue current liver-healthy habits. No intervention needed.
Kidney function is normal with age-appropriate eGFR. No proteinuria indicators.
Maintain adequate hydration. Annual monitoring is sufficient.
All red blood cell parameters are optimal. No signs of iron deficiency or B12/folate deficiency.
No intervention needed. Continue balanced nutrition.
All 39 biomarkers with reference ranges and trends
| Biomarker | Value | Reference | Status | Trend | |
|---|---|---|---|---|---|
Comprehensive Metabolic Panel | |||||
| Glucose(GLU) | 94mg/dL | 70–100 | Normal | ||
| Blood Urea Nitrogen(BUN) | 16mg/dL | 7–20 | Optimal | ||
| Creatinine(CRE) | 0.85mg/dL | 0.6–1.2 | Optimal | ||
| eGFR(eGFR) | 88mL/min/1.73m² | 60–120 | Normal | ||
| Sodium(Na) | 140mEq/L | 136–145 | Optimal | ||
| Potassium(K) | 4.2mEq/L | 3.5–5 | Optimal | ||
| Chloride(Cl) | 102mEq/L | 98–106 | Optimal | ||
| Carbon Dioxide(CO2) | 24mEq/L | 23–29 | Optimal | ||
| Calcium(Ca) | 9.6mg/dL | 8.5–10.5 | Optimal | ||
| Total Protein(TP) | 7.1g/dL | 6–8.3 | Optimal | ||
| Albumin(ALB) | 4.3g/dL | 3.5–5.5 | Optimal | ||
| Bilirubin, Total(TBIL) | 0.8mg/dL | 0.1–1.2 | Optimal | ||
| Alkaline Phosphatase(ALP) | 68U/L | 44–147 | Optimal | ||
| AST (SGOT)(AST) | 24U/L | 10–40 | Optimal | ||
| ALT (SGPT)(ALT) | 28U/L | 7–56 | Optimal | ||
Complete Blood Count | |||||
| White Blood Cells(WBC) | 6.2K/uL | 4.5–11 | Optimal | ||
| Red Blood Cells(RBC) | 4.52M/uL | 3.77–5.28 | Optimal | ||
| Hemoglobin(HGB) | 13.8g/dL | 11.1–15.9 | Optimal | ||
| Hematocrit(HCT) | 41.2% | 34–46.6 | Optimal | ||
| MCV(MCV) | 91.2fL | 79–97 | Optimal | ||
| MCH(MCH) | 30.5pg | 26.6–33 | Optimal | ||
| MCHC(MCHC) | 33.5g/dL | 31.5–35.7 | Optimal | ||
| RDW(RDW) | 13.1% | 11.7–15.4 | Optimal | ||
| Platelets(PLT) | 245K/uL | 150–379 | Optimal | ||
| Neutrophils(NEU) | 58% | 40–74 | Optimal | ||
| Lymphocytes(LYM) | 32% | 14–46 | Optimal | ||
| Monocytes(MON) | 7% | 4–12 | Optimal | ||
| Eosinophils(EOS) | 2% | 0–7 | Optimal | ||
| Basophils(BAS) | 1% | 0–3 | Optimal | ||
Lipid Panel | |||||
| Total Cholesterol(TC) | 218mg/dL | 100–199 | High | ||
| LDL Cholesterol(LDL) | 138mg/dL | 0–129 | High | ||
| HDL Cholesterol(HDL) | 62mg/dL | 39–100 | Optimal | ||
| Triglycerides(TG) | 142mg/dL | 0–149 | Borderline | ||
| VLDL Cholesterol(VLDL) | 28mg/dL | 5–40 | Normal | ||
| TC/HDL Ratio(TC/HDL) | 3.5ratio | 0–5 | Optimal | ||
| LDL/HDL Ratio(LDL/HDL) | 2.2ratio | 0–3.6 | Normal | ||
Inflammatory Markers | |||||
| C-Reactive Protein (hs)(hsCRP) | 1.8mg/L | 0–3 | Borderline | ||
| Erythrocyte Sedimentation Rate(ESR) | 14mm/hr | 0–20 | Normal | ||
| Homocysteine(HCY) | 8.2umol/L | 0–15 | Optimal | ||
Evidence-based actions to optimize your blood markers
Adopt a Mediterranean-style eating pattern emphasizing olive oil, fatty fish, nuts, legumes, and abundant vegetables to lower LDL cholesterol and reduce inflammation.
Clinical trials show Mediterranean diet reduces LDL by 10-15% and hsCRP by 20-30% within 3 months.
Supplement with 2-4g of combined EPA/DHA daily from high-quality fish oil to lower triglycerides and reduce systemic inflammation.
Triglycerides at 142 mg/dL are borderline. Omega-3s at therapeutic doses can reduce TG by 20-30%.
Engage in 150+ minutes per week of moderate-intensity aerobic exercise (brisk walking, cycling, swimming) to improve lipid profile and insulin sensitivity.
Regular aerobic exercise raises HDL by 5-10%, lowers LDL by 5-10%, and improves glucose metabolism.
Limit added sugars, white bread, pasta, and processed foods. Replace with whole grains, legumes, and fiber-rich foods.
Refined carbs drive triglyceride production. Reducing intake can lower TG by 15-25% and improve fasting glucose.
Add 2g/day of plant sterols or stanols (available in fortified foods or supplements) to help block cholesterol absorption.
Plant sterols can reduce LDL cholesterol by 6-15% when combined with dietary changes.
Practice daily stress reduction (meditation, deep breathing) and aim for 7-8 hours of quality sleep to reduce cortisol-driven inflammation.
Chronic stress elevates hsCRP and cortisol, which can worsen lipid profiles and inflammatory markers.
After implementing dietary and lifestyle changes, recheck the full lipid panel and hsCRP to assess progress. Consider HbA1c testing.
Three months allows sufficient time for lifestyle interventions to show measurable biomarker improvements.
Changes since Aug 15, 2025
Previous
Current
Change
How this report was generated
This comprehensive blood panel report analyzes biomarkers from three standard panels: Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC), and Lipid Panel. Reference ranges are based on established clinical laboratory standards and may vary slightly between laboratories.
Optimal ranges represent narrower windows within the normal reference range that are associated with the best health outcomes based on current medical literature. These are more aspirational targets than diagnostic thresholds.
Organ system scores are composite calculations derived from the biomarkers most relevant to each system. Risk assessments use established clinical algorithms incorporating multiple biomarker values and their interactions.
AI-generated summaries use large language models to provide personalized narrative analysis. While the AI considers all biomarker values and their clinical significance, it is not a substitute for professional medical interpretation.
This report is for informational purposes only and does not constitute medical advice. Always consult with your healthcare provider for interpretation of lab results and any changes to your health regimen.